Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients

American Journal of Transplantation

Volumn 7, Issue 11, 2007, Pages 2567-2572

  Manuel, O ^a   Humar, A ^a   Chen, M H ^b   Chernenko, S ^b   Singer, L G ^b   Cobos, I ^a   Kumar, D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Influenza vaccine; Intradermal route; Lung transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; INFLUENZA VACCINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; DRUG FEVER; DRUG INDUCED DISEASE; DRUG SAFETY; ERYTHEMA; FATIGUE; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOGENICITY; INFLUENZA; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PRURITUS; TENDERNESS; TREATMENT RESPONSE; VACCINATION; VOMITING;

ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFLUENZA VACCINES; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; SAFETY; VACCINATION; VACCINES, INACTIVATED;

EID: 35248874254     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01982.x     Document Type: Article

References (27)

1. Vilchez RA, McCurry K, Dauber J et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002 2 : 287 291.
2. Kumar D, Erdman D, Keshavjee S et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005 5 : 2031 2036.
3. Vilchez RA, Dauber J, Kusne S. Infectious etiology of bronchiolitis obliterans: The respiratory viruses connection - myth or reality Am J Transplant 2003 3 : 245 249.
4. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004 4 (s10 160 163.
5. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 2001 18 : 971 976.
6. Gravenstein S, Drinka P, Duthie EH et al. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J Am Geriatr Soc 1994 42 : 245 251.
7. Kemble G, Greenberg H. Novel generations of influenza vaccines. Vaccine 2003 21 : 1789 1795.
8. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000 61 : 85 93.
9. Blumberg EA, Albano C, Pruett T et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996 22 : 295 302.
10. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998 17 : 1075 1080.
11. Admon D, Engelhard D, Strauss N, Goldman N, Zakay-Rones Z. Antibody response to influenza immunization in patients after heart transplantation. Vaccine 1997 15 : 1518 1522.
12. Ada G. Vaccines and vaccination. N Engl J Med 2001 345 : 1042 1053.
13. Moll H. Antigen delivery by dendritic cells. Int J Med Microbiol 2004 294 : 337 344.
14. Moll H, Berberich C. Dendritic cells as vectors for vaccination against infectious diseases. Int J Med Microbiol 2001 291 : 323 329.
15. Steinman RM, Pope M. Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 2002 109 : 1519 1526.
16. Belshe RB, Newman FK, Cannon J et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004 351 : 2286 2294.
17. Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004 351 : 2295 2301.
18. World Health Organization. Recommendations for influenza vaccine composition. Northern Hemisphere, 2006-2007. Available at : http://www.who.int./ csr/disease/influenza/vaccinerecommendations1/en/index2.html.
19. Gelder CM, Lambkin R, Hart KW et al. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 2002 185 : 114 117.
20. McElhaney JE, Xie D, Hager WD et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006 176 : 6333 6339.
21. Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures data. Stat Med 2000 19 : 1793 1819
22. Choy BY, Peiris JS, Chan TM, Lo SK, Lui SL, Lai KN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant 2002 2 : 965 969.
23. Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007 25 : 659 663.
24. Khanlou H, Sanchez S, Babaie M et al. The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients. Arch Intern Med 2006 166 : 1417.
25. Womer KL, Peng R, Patton PR et al. The effects of renal transplantation on peripheral blood dendritic cells. Clin Transplant 2005 19 : 659 667.
26. Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB. Influenza vaccine antibody responses in lung transplant recipients. Prog Transplant 2004 14 : 346 351.
27. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Mauer JR. Cell-mediated immune response to influenza vaccination in lung transplant recipients. J Heart Lung Transplant 2004 10 : 1175 1181.